A little over a year ago, Accenture formed the Life Sciences Cloud Coalition, a governing body of the Accenture Life Sciences Cloud for R&D (ALSC) platform. ALSC speeds clinical development, helps improve patient outcomes and creates greater R&D efficiency through a single analytics platform that combines multiple internal and external data sources from across clinical, safety, regulatory and operational functions. Our vision for the Life Sciences Cloud Coalition was to assemble like-minded leaders to collaborate in non-competitive areas for a healthier industry. Representative members include Eisai, Merck, Pfizer and others.
Expanding participation and scope
For the first time since its inception, the Life Sciences Cloud Coalition expanded participation beyond technical and functional experts to include business leaders from the member pharmaceutical companies. Additionally, the scope of R&D functional areas addressed by the coalition members was expanded to include regulatory and safety capacities.
The expansion of the coalition charter aligns with Accenture’s ongoing initiatives to fold in additional capabilities across the drug development lifecycle, including Quantum MDR, Accenture’s metadata registry solution, which helps life sciences companies master complex metadata management challenges by providing a single application to manage clinical data standards.
One of the highlights of this quarter’s cross-industry meeting was a member-led round-robin discussion on key topics, including:
Adding additional safety analytics capabilities to the Accenture Life Sciences Cloud platform.
Using the new unstructured content and search features within the platform to create an “Evidence Compendium.”
The Accenture team also confirmed the near-term technology priorities and architecture roadmap for advancing the ALSC platform to meet client needs, and showcased a preview of the features included in ALSC version 3.0, which will be released soon.
Coalition members also worked through a collaborative agreement on the overarching governance model for ongoing coalition meetings and committed to a series of more frequent working sessions to explore the functional requirements needed to extend the multi-client platform.
The success of the Life Sciences Cloud Coalition is evident not only in the expanding level of participation by industry representatives, but also in the energy participants bring to the discussion. The next coalition meeting is scheduled for February, 2015.